Prawo i regulacje · 09/03/2017

US Drug Enforcement Administration Schedules Brivaracetam as Schedule V Controlled Substance

The Drug Enforcement Administration has finalized a rule placing the medication brivaracetam into Schedule V of the Controlled Substances Act, following a request for comments published in 2016 and a law signed into effect in 2015.